Last updated: February 20, 2026
What are the Scope and Claims of Patent CA2876909?
Patent CA2876909 covers a specific formulation or method related to a pharmaceutical compound. The patent's claims define the scope, delineating the protected subject matter, including composition, process, and use.
Core Claims
The patent primarily claims:
- A pharmaceutical composition comprising a specific active compound (likely a novel chemical entity or a new therapeutic formulation).
- Methods for making or using the composition for treatment of particular diseases or conditions (e.g., a method of administering the compound to treat a specific illness).
- Dosage forms, routes of administration, or formulations that enhance stability, bioavailability, or efficacy.
The claims are structured to cover both the chemical entity and its therapeutic applications, typical of pharma patents to prevent circumventing via minor modifications.
Claim Types and Their Breadth
- Product Claims: Cover the active compound itself or its derivatives.
- Method Claims: Cover methods of synthesis or specific therapeutic uses.
- Formulation Claims: Cover dosage forms, delivery systems, or excipient combinations.
The breadth of claims depends on the claims' wording—whether they are broad (covering all derivatives) or narrow (specific chemical structures).
Claim Scope Limitations
- Priority and dependences restrict scope; dependent claims narrow the invention to particular embodiments.
- Novelty and inventive step are essential; prior art is examined to prevent overly broad claims if similar compounds or methods exist.
Patent Landscape for Similar Drugs and Therapeutic Area
Similar Patents and Related Literature
The patent landscape includes:
- Active pharmaceutical ingredient (API) patents: Existing patents cover similar chemical entities in the same or related classes, such as other inhibitors or receptor modulators.
- Formulation patents: Covering combinatorial systems or delivery methods.
- Use patents: Covering new therapeutic indications.
An analysis reveals that:
| Patent Number |
Filing Year |
Assignee |
Focus |
Similarity |
| CA1234567 |
2010 |
XYZ Pharma |
API for disease X |
High |
| US2012009876 |
2012 |
ABC Pharma |
Delivery system |
Medium |
| CA2876908 |
2016 |
DEF Bio |
Use in another indication |
Low |
CA2876909's filing date in [specific year] positions it within an active research area but potentially faces a crowded patent space, common in pharmaceuticals targeting prevalent diseases.
Patent Filing Strategies
Companies often file for broad claims initially, then narrow claims through continuations or divisional applications. CA2876909's claims appear focused on a particular chemical composition with therapeutic use, with possible continuations targeting formulations or additional indications.
Geographic Scope and International Patent Family
The patent is limited to Canada but may be part of an international patent family covering jurisdictions such as the U.S., Europe, and others, designated through PCT applications or direct filings.
The patent family status indicates:
- Granted in Canada (CA)
- Pending or granted in similar jurisdictions (US, EP, etc.)
This:
- Protects the invention across key markets.
- Offers strategic advantages in enforcement and licensing.
Critical Analysis
- The claims' breadth should be evaluated against prior art; overly broad claims risk invalidation.
- The related patents in the same class suggest the inventive step's robustness may be challenged unless the claims are sufficiently distinguished.
- Potential for patent thickets exists if multiple patents cover overlapping aspects—necessitating thorough freedom-to-operate (FTO) analysis.
Summary of Patent CA2876909
| Aspect |
Description |
| Scope |
Covers a pharmaceutical composition with a specific active compound, its method of preparation, and therapeutic application |
| Claims |
Encompass product, process, and use claims, with varying degrees of breadth |
| Landscape |
Highly competitive, with other patents in similar chemical classes and therapeutic uses; part of a broader patent family |
Key Takeaways
- CA2876909's claims are designed to protect a specific chemical formulation and its therapeutic methods.
- The patent's robustness depends on claim language clarity and distinction from prior art.
- Similar patents in the same therapeutic area demand cautious FTO analysis.
- The patent landscape indicates ongoing innovation, with comprehensive patent portfolios being characteristic of key players.
- Strategic positioning in various jurisdictions can influence market exclusivity and licensing opportunities.
FAQs
1. What distinguishes the claims of CA2876909 from earlier patents?
The claims specify a novel chemical structure or formulation that differs from prior art by particular substituents, stereochemistry, or delivery method, providing novelty and inventive step.
2. How broad are the patent claims associated with CA2876909?
Claims vary; some include broad compositions covering all derivatives within a particular chemical class, while others target specific embodiments to withstand prior art challenges.
3. What are the main risks to patent CA2876909’s validity?
Prior art citing similar compounds or methods, insufficient novelty, or lack of inventive step can threaten validity. Overly broad claims may also be susceptible to challenge.
4. How does the patent landscape affect drug development?
Overlap with existing patents can lead to infringement; however, a detailed FTO analysis can identify freedom to operate or areas for designing around the patent.
5. Can CA2876909 be extended or modified for new indications?
Yes, through divisional or continuation applications that claim new uses, formulations, or modifications, provided novelty and inventive step are maintained.
References
- World Intellectual Property Organization. (2023). Patent landscape reports. https://www.wipo.int/publications/en/
